Patient reported outcome data from acromegaly patients treated with injectable somatostatin receptor ligands (SRLs) in routine clinical practice

Patient reported outcome data from acromegaly patients treated with injectable somatostatin receptor ligands (SRLs) in routine clinical practice

Abstract Background Acromegaly patients managed on Somatostatin receptor ligands (SRLs), the most common first-line pharmacotherapy for acromegaly, may still experience acromegaly symptoms such as headache, sweating, fatigue, soft tissue swelling, and joint pain, even those with normal IGF-1. Additi...

Full description

Bibliographic Details
Main Authors: Eliza B. Geer, Jill Sisco, Daphne T. Adelman, William H. Ludlam, Asi Haviv, Shuqian Liu, Susan D. Mathias, Dana Gelbaum, Lizheng Shi
Format: Article
Language:English
Published: BMC 2020-07-01
Series:BMC Endocrine Disorders
Subjects:
Acromegaly
Somatostatin receptor ligands
Treatment satisfaction
Patient reported outcomes
Questionnaire
Online Access:http://link.springer.com/article/10.1186/s12902-020-00595-4

Internet

http://link.springer.com/article/10.1186/s12902-020-00595-4

Similar Items